Literature DB >> 8943744

Prevalence of human herpesvirus 6 in lung tissue from children with pneumonitis.

J A Hammerling1, R S Lambrecht, K S Kehl, D R Carrigan.   

Abstract

AIMS/
BACKGROUND: Human herpesvirus type 6 (HHV-6) is the aetiological agent of exanthem subitum, and has also been linked with a variety of other diseases. The aim of this study was to investigate the role of HHV-6 in pneumonitis in children.
METHODS: Formalin fixed, paraffin wax embedded lung tissue from 33 children (age range two months to 16 years) who died with pneumonitis was subjected to immunohistochemical staining for HHV-6 using an avidin-biotin method.
RESULTS: Active HHV-6 infection was demonstrated in four children: a bone marrow transplant recipient with concomitant adenovirus infection, a patient with hepatitis of unknown aetiology, a patient with congenital anomalies, and a patient with congenital immunodeficiency.
CONCLUSION: Accurate localisation of HHV-6 is possible in postmortem lung tissue. HHV-6 either alone or in combination with other pathogens may play a role in the development of pneumonitis.

Entities:  

Mesh:

Year:  1996        PMID: 8943744      PMCID: PMC500772          DOI: 10.1136/jcp.49.10.802

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

Review 1.  Human herpesvirus 6: the virus and the search for its role as a human pathogen.

Authors:  P E Pellett; J B Black; M Yamamoto
Journal:  Adv Virus Res       Date:  1992       Impact factor: 9.937

2.  Pneumonitis associated with coinfection by human herpesvirus 6 and Legionella in an immunocompetent adult.

Authors:  S K Russler; M A Tapper; K K Knox; A Liepins; D R Carrigan
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

3.  Human herpesvirus-6 infection with liver injury in neonatal hepatitis.

Authors:  H Tajiri; O Nose; K Baba; S Okada
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

4.  Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection.

Authors:  Y Asano; T Yoshikawa; S Suga; T Yazaki; K Kondo; K Yamanishi
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

5.  Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

Authors:  P Lusso; B Ensoli; P D Markham; D V Ablashi; S Z Salahuddin; E Tschachler; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

6.  Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6.

Authors:  D R Carrigan; K K Knox; M A Tapper
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

7.  Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues.

Authors:  C B Toorkey; D R Carrigan
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

8.  Human herpesvirus 6 (HHV-6)-associated dysfunction of blood monocytes.

Authors:  E M Burd; D R Carrigan
Journal:  Virus Res       Date:  1993-07       Impact factor: 3.303

9.  Immunohistological detection of human herpes virus 6 in formalin-fixed, paraffin-embedded lung tissues.

Authors:  A K Pitalia; J A Liu-Yin; A J Freemont; D J Morris; R J Fitzmaurice
Journal:  J Med Virol       Date:  1993-10       Impact factor: 2.327

10.  Progressive immunodeficiency and fatal pneumonitis associated with human herpesvirus 6 infection in an infant.

Authors:  K K Knox; D Pietryga; D J Harrington; R Franciosi; D R Carrigan
Journal:  Clin Infect Dis       Date:  1995-02       Impact factor: 9.079

View more
  3 in total

1.  Impact of human herpes virus 6 in liver transplantation.

Authors:  Raymund R Razonable; Irmeli Lautenschlager
Journal:  World J Hepatol       Date:  2010-09-27

Review 2.  Chromosomally integrated human herpesvirus 6: questions and answers.

Authors:  Philip E Pellett; Dharam V Ablashi; Peter F Ambros; Henri Agut; Mary T Caserta; Vincent Descamps; Louis Flamand; Agnès Gautheret-Dejean; Caroline B Hall; Rammurti T Kamble; Uwe Kuehl; Dirk Lassner; Irmeli Lautenschlager; Kristin S Loomis; Mario Luppi; Paolo Lusso; Peter G Medveczky; Jose G Montoya; Yasuko Mori; Masao Ogata; Joshua C Pritchett; Sylvie Rogez; Edward Seto; Katherine N Ward; Tetsushi Yoshikawa; Raymund R Razonable
Journal:  Rev Med Virol       Date:  2011-11-04       Impact factor: 6.989

Review 3.  Antiviral therapy for respiratory tract infections.

Authors:  Samson S Y Wong; Kwok-Yung Yuen
Journal:  Respirology       Date:  2008-11       Impact factor: 6.424

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.